Immune effector cell hybrids
Details for Australian Patent Application No. 2003271378 (hide)
International Classifications
Event Publications
22 January 2004 Complete Application Filed
29 January 2004 Application Open to Public Inspection
Published as AU-B-2003271378
25 January 2007 Application Accepted
Published as AU-B-2003271378
24 May 2007 Standard Patent Sealed
9 October 2008 Offer to Surrender
Genzyme Corporation One Mountain Road PO Box 9322 , DanaFramingham Massachusetts 01701-9322; Farber Cancer Institute, Inc. 44 Binney Street , Boston MA 02115, the Patentee of Letters Patent 2003271378 dated 11.05.2007 for an invention titled ' Immune effector cell hybrids' offers to surrender the said Letters Patent. Any person desiring to be heard before the said offer to surrender is accepted must lodge a request to be heard within one month from the date of this journal.
27 November 2008 Innovation Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser